首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Increase in hospital-acquired bloodstream infections caused by extended spectrum beta-lactamase-producing Escherichia coli in a large French teaching hospital.
【24h】

Increase in hospital-acquired bloodstream infections caused by extended spectrum beta-lactamase-producing Escherichia coli in a large French teaching hospital.

机译:在法国的一家大型教学医院中,由于产生广谱β-内酰胺酶的大肠杆菌引起的医院获得性血液感染的增加。

获取原文
获取原文并翻译 | 示例
       

摘要

Our goal was to determine the characteristics and the mode of acquisition of healthcare-associated bacteraemia due to CTX-M-producing Escherichia coli in a 1,800-bed hospital. Sixteen extended-spectrum beta-lactamase (ESBL)-producing E. coli strains were collected between 2001 and 2006 from patients with bloodstream infections. The incidence density of these infections increased from 0.002 to 0.02 per 1,000 days of hospitalisation during the study period. Most of the strains (87%) produced a CTX-M-type enzyme associated with TEM-1 (86%), OXA-30 (50%), AAC(3)-II (57%), AAC(6') (50%) and QnrS1 (7%). When present (n = 8), the bla (CTX-M-15) gene was always located downstream of the insertion sequence ISEcp1. Co-resistance was generally observed: fluoroquinolones (81%), trimethoprim-sulfamethoxazole (62%) and/or aminoglycosides (69%). Although the strains were found to be genetically unrelated, most of the cases were hospital-acquired (69%) or healthcare-associated (25%), underlining the need for infection control measures to limit the spread of ESBL-producing E. coli in hospital settings.
机译:我们的目标是确定在拥有1800张病床的医院中生产CTX-M的大肠杆菌引起的医疗保健相关菌血症的特征和获取方式。在2001年至2006年之间,从患有血液感染的患者中收集了16株产生超广谱β-内酰胺酶(ESBL)的大肠杆菌。在研究期间,每1,000天住院期间,这些感染的发生率从0.002增至0.02。大多数菌株(87%)产生与TEM-1(86%),OXA-30(50%),AAC(3)-II(57%),AAC(6')相关的CTX-M型酶(50%)和QnrS1(7%)。当存在(n = 8)时,bla(CTX-M-15)基因始终位于插入序列ISEcp1的下游。通常观察到共耐药性:氟喹诺酮类(81%),甲氧苄啶-磺胺甲基恶唑(62%)和/或氨基糖苷(69%)。尽管发现该菌株与遗传无关,但大多数病例是医院获得的(69%)或医疗保健相关的(25%),强调需要采取感染控制措施以限制生产ESBL的大肠杆菌在美国的传播。医院设置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号